News A Conversation with Katharine Ku, Chief Licensing Advisor at WSGR Attorneys Vern Norviel and Charles Andres recently sat down with Katharine "Kathy" Ku, WSGR’s new chief licensing advisor, to discuss…Super UserJune 24, 2019
News Frederick National Labs Attract Entrepreneurs and Collaborators Seeking Leading-Edge Biomedical Technologies · BioBuzz The National Cancer Institute (NCI) and The Frederick National Laboratory for Cancer Research (FNLCR) recently hosted the third annual Technology…Super UserJune 24, 2019
News Four BIOE Ph.D. Students Awarded NIH Fellowships | Fischell Department of Bioengineering Fischell Department of Bioengineering (BIOE) Ph.D. students Michelle Bookstaver, John Daristotle, Mary Doolin, and Emily Gosselin were recently named recipients…Super UserJune 24, 2019
News Qiagen launches one-stop antimicrobial resistance database alongside CDC commitment | FierceBiotech In the face of growing international concerns over antimicrobial resistance, Qiagen has launched a one-stop shop that compiles publicly available…Super UserJune 24, 2019
News NHLBI Funding & Research Opportunities and Announcements for May 31, 2019 Funding and Research Opportunities The following funding opportunity announcements from the NHLBI or other components of the National Institutes of…Super UserJune 24, 2019
News Pfizer to buy Array BioPharma for $11.4B – MedCity News A large pharmaceutical company is spending more than $11 billion to acquire the maker of two drugs used to treat…Super UserJune 24, 2019
News This Baltimore-based venture capital firm is looking to invest in D.C.-area startups – Technical.ly DC Baltimore-Md.-based Inner Loop Capital is giving D.C.-area startups a financial boost with this new fund. (more…)Super UserJune 24, 2019
News AstraZeneca to invest $630 million in Korean biohealth sector – Korea Biomedical Review AstraZeneca said it would invest $630 million into Korea’s biotech and healthcare sector over the next five years. Leif Johansson,…Super UserJune 24, 2019
News Viela Bio Closes $75 Million Series B Financing – Business Wire Viela Bio today announced the successful completion of a $75 million private placement of its Series B preferred stock, bringing…Super UserJune 24, 2019
News CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company that is focusing on developing and accelerating the launch of innovative…Super UserJune 24, 2019